Biotechnology

1. Biotechnology industry career resources: Career listings, career tips and information, and sala - Biotechnology industry career resources: Career listings, career tips and information, and salary surveys. biotech.about.com Mama
2. From Alchemy to IPO- The Business of Biotechnology

   From Alchemy to IPO

   The Business of Biotechnology:
   • Book by Cynthia Robbins-Roth.
3. Biotechnology company location: Issues in biotechnology company regional and local site selecti - Issues in biotechnology company regional and local site selection. The importance of factors such as access to capital and skilled workers. biotech.about.com Mama
4. Biotechnology - The Controversy Surrounding Biotechnology - Biopatents and biotechnology has raised ethical concerns and biopiracy rears its ugly head. inventors.about.com Mama
5. The Debate Over Food Biotechnology - Edward Groth III, Ph.D.,Senior Scientist, Consumers Union of United States, Inc., reports how fluoridation proponents went wrong in their efforts to encourage Americans to drink fluoridated water. www.consumersunion.org Mama
6. AgBiotechNet - Abstracts Database - This site contains news, reviews, abstracts, reports, jobs, conferences and links on agricultural biotechnology, including animals. www.agbiotechnet.com Mama
7. BioSpace - Up-to-date industry news, stock quotes, company information, job postings and industry resources for all publicly traded biotechnology and pharmaceutical companies. www.biospace.com Mama
8. Current Pharmaceutical Biotechnology - Current Pharmaceutical Biotechnology aims to cover all the latest and outstanding developments in pharmaceutical biotechnology. www.bentham.org Mama
9. Biotechnology - Manufacturers, researchers and drug developers using cloning, genetics and genomics. www.business.com Mama
10. Insight Biotechnology limited supply high quality reagents for cell and... - Insight Biotechnology limited supply high quality reagents for cell and molecular biology, specializing in antibodies for medical research. PRODUCT SEARCH ... www.insightbio.com Mama
11. Our Posthuman Future- Consequences of the Biotechnology Revolution

    Our Posthuman Future

    Consequences of the Biotechnology Revolution:
    • Book by Francis Fukuyama.
12. Boston Business Journal: Biotechnology - ... Boston Business Journal: Biotechnology Members: Log in Not ... boston.bizjournals.com Mama
13. Polish Biotechnology News - News about biotechnology development in Poland. www.biotechnology-pl.com Mama
14. Issues in biotechnology company regional and local site selection. - Issues in biotechnology company regional and local site selection. biotech.about.com Mama
15. International Biotechnology: News and information on biotechnology industries and biotechnology - News and information on biotechnology industries and biotechnology growth outside of the Unites States. biotech.about.com Mama
16. Ausbiotech - Australia's Biotechnology Organisation, entrepreneurial bioscie... - ... [AusBiotech]Create? can see the benefit of co-locating with a sympathetic company interested in Biotechnology. If you are interested please contact Mario Nobrega at [GormanKelly]Create? directly on: Ph: 9810 7222 Fax ... www.ausbiotech.org Mama
17. Venture Capital Industry Focus on Biotechnology - Venture capitalists focused on the biotechnology industry. www.business.com Mama
18. "Leaders In Online Education" - Let us Help you Advance your Education - Get a degree online! Request free information from top schools here and get your degree fast. www-college.org Mama
19. New York Biotechnology Association - Visit the link for details. www.nyba.org Mama
20. Environmental Biotechnology- Principles and Applications

    Environmental Biotechnology

    Principles and Applications:
    • Book by Bruce E. Rittmann and Perry L. [McCarty]Create?.
21. The Scientist's Guide to Traditional and Alternative Careers - Features news articles and essays by scientists on how to find a job. Covers phd level occupations. Includes bioinformatics and Seattle biotechnology links. www.geocities.com Mama
22. MBC: Massachusetts Biotechnology Council - Courses. Biotechnology Project Management 5 January - 26 January 2006 ... to become a successful Project Manager in a biotechnology company. ... www.massbio.org Mama
23. Biotechnology Patents - ... related to Biotechnology patents *. Full text Biotechnology Patents: ( ... Biotechnology: Patenting Issues - Bibliography (Records from Agricola ... www.nal.usda.gov Mama
24. BBSRC - the Biotechnology and Biological Sciences Research Council - ... International Activities International linkages and funding contribute to the UK's leading position in many areas of biotechnology & biological sciences. [more international...] Science & Society ... www.bbsrc.ac.uk Mama
25. Global Issues - Biotechnology - Presents speeches, articles and links on biotechnology policy, regulations, and science. The page is maintained by the Office of International Information Programs. usinfo.state.gov Mama
26. Biotechnology Business Development: Issues in developing biotechnology companies. - page 2 of 2 - Issues in starting-up or growing a biotechnology business. Alliances, B2B, Business Models, Drug Development, Funding, Licensing, Management, Commercialization, M&A, Outsourcing, Strategies, and more. biotech.about.com Mama
27. Cuban Center for Genetic Engineering and Biotechnology - Offers assistance to commercialize Cuban biotechnology. Site includes research profile, news and links to other Cuban biotechnology sites. gndp.cigb.edu.cu Mama
28. Biotechnology MSc at Otago - Information on biotechnology research and education at the University of Otago and commercial biotechnology in Dunedin osms.otago.ac.nz Mama
29. Biotechnology- An Introduction (with InfoTrac)

    Biotechnology

    An Introduction (with [InfoTrac]Create?):

• Book by Susan R. Barnum.

From Alchemy to IPO- The Business of Biotechnology

From Alchemy to IPO

The Business of Biotechnology:

"A tour-de-force for anyone who is interested in the biotech industry. I applaud the enormous achievement of Cynthia Robbins-Roth." -Frederick Frank, Senior Managing Director & Vice Chair, Lehman Brothers

"From Alchemy to IPO tells the dramatic story of this revolutionary industry as only an insider can." -George Rathmann, President and CEO, ICOS Corporation, Chairman Emeritus, Amgen

Written by a well-known industry insider, From Alchemy to IPO addresses the coming-of-age of biotech products and companies and traces the history of biotechnology from its early inception in the seventies to today's heyday of new solutions and breakthrough treatments. It describes the amazing entrepreneurial trail of product development, novel business models, and critical trials that eventually pave the way to market. This is the first book to accurately record the inner workings of an industry-biotechnology-that's on the verge of living up to its monumental promise to change the world as we know it.

• Review:: 'Good introductory text and overview of the industry I read From Alchemy to IPO for an MBA course on entrepreneurialism in the pharmaceutical industry. Given my background (undergraduate business, financial analyst role, limited in-depth scientific knowledge), I found this book to be a very useful and balanced guide to both the business and technical aspects of biotechnology. Robbins-Roth includes enough information on initial public offerings (IPOs) and merger activity among biotech firms to warm the hearts of the most resolute business student, but the drug discovery and development process is also covered in sufficient detail to give the lay reader an understanding for the operational challenges faced by firms in this sector. Add to this the competent yet necessarily superficial descriptions of more esoteric terms such as monoclonal antibodies and combinatorial chemistry, and you have a solid text that covers the industry and its ongoing challenges very well.
• Review:: 'Brilliant Overview This is a great overview of the world of biotech. The author explains the science with clarity and enthusiasm and the introduction this book provides to the corporate side of biotech is also very interesting and well written.
• Review:: 'bad writing I read the first 20 pages of this book and quit. It was too painful to keep going. The author's wording in convoluted, tangential, and just plain annoying. She throws out dozens of names from the industry, so many you can't keep them straight. There is poor flow to the writing, so you cannot understand why she is telling you things from one line to the next. The topics of each paragraph jump from one subject to another with abrupt, confusing transitions. I returned the book!
• Review:: 'Clear and non hyped intro into biotech I'll be starting a biomedical engineering Ph.D. program in the fall and have read recently a few books on the biotech subject. This one gave the clearest picture of the biotech industries, the companies in them, how to manage and finance them, as well as how to recognize solid biotech companies for investing purposes. A quick and entertaining read for anyone interested in the business behind biotechnology.
• Review:: 'WAY OVERRATED BOOK ON BIOTECH to quote another user: "The author's expertise in science, finance, management strategy, and journalism..." the author can write decently and she may know about biotech (hard to judge for me not being a scientist)...BUT her knowledge about management strategy and finance is limited at best...that wouldnýt be so bad if she were to stick to write about science...however, she thinks she knows about finance and strategy...who wants to read about strategy should stick with hamel, pralahad, porter etc., who wants to read about finance (valuation) should stick with copeland et al, and who wants to read about ipos should try articles by jay ritter.

• Similar books:
• Building Biotechnology- Starting, Managing, And Understanding Biotechnology Companies
• The Billion Dollar Molecule- One Company's Quest for the Perfect Drug
• The Biotech Investor's Bible
• Drugs-From Discovery to Approval
• Building Global Biobrands - Taking Biotechnology to Market

Our Posthuman Future- Consequences of the Biotechnology Revolution

Our Posthuman Future

Consequences of the Biotechnology Revolution:

Fukuyama is deeply concerned about the erosion of the foundations of liberal democracy under pressure from new concepts of humans and human rights, and most readers will find some room for agreement. Ultimately, he argues for strong international regulation of human biotechnology and thoughtfully disposes of the most compelling counterarguments. While readers might not agree that we're at risk of creating Huxley's Brave New World, it's hard to deny that things are changing quickly and that perhaps we ought to consider the changes before they're irrevocable. --Rob LightnerDescription: A decade after his now-famous pronouncement of 'the end of history,' Francis Fukuyama argues that as a result of biomedical advances, we are facing the possibility of a future in which our humanity itself will be altered beyond recognition. Fukuyama sketches a brief history of man's changing understanding of human nature: from Plato and Aristotle to the modernity's utopians and dictators who sought to remake mankind for ideological ends. Fukuyama argues that the ability to manipulate the DNA of all of one person's descendants will have profound, and potentially terrible, consequences for our political order, even if undertaken with the best of intentions. In Our Posthuman Future, one of our greatest social philosophers begins to describe the potential effects of genetic exploration on the foundation of liberal democracy: the belief that human beings are equal by nature.Description: Fukuyama, our greatest social philosopher, weaves a captivating argument centered around an essential question: how the ability to modify human behavior will affect liberal democracy.

• Review:: 'Some merit, but overall flawed By arguing that human rights comes from some vague concept of "dignity" and "familiarity" rather than sentience and feeling, Fukuyama brings to mind the European colonists who considered Africans no more than "common beasts." His philosophy, although argued in a tone that seems reasonable, is at turns startingly narrow-minded and genetically-racist. Not reccomended: readers should look otherwheres for a more balanced and less judgemental review of biotechnology and ethics.
• Review:: 'Bush position regarding biotechnology written by somebody else... In this book Fukuyama gives us his thoughts on biotechnology. Basically, he opposes human clonation and any intervention on the design of animals and human beings. Not surprisingly, he was chosen as a member of the President's Council on Bioethics. Even if the book can be read as a communiqué by the American government, its academic quality remains high. Instead of grounding his argument on religious terms (as the American politicians opposed to biolotechnology do) he uses Kant's and other philosophers arguments. Since the writting of Trust, Fukuyama has basically written books that set a political position based on academic terms instead of academic works that derive in a political idea. Because of his approaching to power, Fukuyama is losing among the academical community
• Review:: 'Refreshing breadth and depth Being a physicist with some background in biochemistry and computer science, I have little doubt that humanity will soon control biology at the cellular level, likely making bio-nano bots become our ultimate, universal constructors. Whether this will lead to gray goo or utopia I can't say--we may yet be squashed by a BIG meteor hidden by the sun next week--SPLAT! Should we survive being flattened or being disassembled one molecule at a time, I also have little doubt that humanity is not the final word in Earth-based evolution. In our quest to solve medical problems (cancer, Alzheimer's, blindness, etc.) bio-nano-quantum computing technologies will change us profoundly someday, likely sooner than later, and sex, drugs, beer and other sundry carnal activities will lose their meaning as we know them. What super venal replacements "transcended people" will find is beyond speculation, but they will likely be wild beyond our imagination. One question I often ponder, and which Fukuyama treats, is who will make it IF we make it? Will the AIDS stricken Africans make it? Will only relatively wealthy people make it? Given the steep price of current invitro fertilization, one question I grappled with at a UN panel on cloning was what will happen when only the richest rich can afford to make super offspring? What will our kids do to secure their future against super kids? Or what will Americans do, if, as Fukuyama argues, the United States should severely regulate biotechnology even if other nations don't. Will the wealth and international power gradients grow so fast that only some nations, or a tiny fraction of humanity survives Singularity? Fukuyama's book, refreshingly, enters into these and many other questions and ponderables that we humans need to start confronting. Another great book over which to ponder these points is "War and Peace and War" by Turchin, on the mathematical modeling of the history of the rise and fall of civilizations. Turchin's book is very accessible, and very compelling, and may lead you to read his more hardcore historical dynamics texts. The book Citizen Cyborg does a pretty good job on discussing what kind of political systems we should strive for to make sure all make it to Singularity. I also explore all of these ideas and more in my history-based strong science fiction book Beyond Future Shock about the near-terms perils and promise of advanced bio/nano technology in a world still roiled with Middle Age religious conflict and ever growing extreme wealth gradients. Alex
• Review:: 'Bio-tech Neo-Lidite?? O.K. I didn't buy the book, but I searched for reference to "immortality", which, as I suspected would give a very concise philisophical snapshot of the author. Lets see now, he speaks of the "demographic" problems associated with longer life and lower firtility. First obvious flaw in his reasoning is that we would be marginally active and retire for the last 40 to 50 or so years of a radically extended life(or 1000 years or so). The premise is rediculous because the goal of adult onset gene doping would be to extend health and vitality. Immaging a world in which you could live to 150 years or so with the strength and clearity of a 40 or 30 year old? Are you going to just "sit down in your rocking chair"? Even going with the worker ratios, in Japan for instance that he speaks of, only 2 for every 1 retired, we could adjust the theory that social security operates-if you retire at age 65 with indefinite life span, you should collect for just 20 years-go back to work, start a business. Go back to school-learn something new-all better ideas than just infering that we should just roll over and die because redical life extension might cause some potential "problems" with systems put in place when humans were suffering and dying at young ages. Also, "age differences" between the developed world and the underdeveloped world. Yes, there will be definate philosophic differences but they exist for other reasons rather than just "older women"(refering to aging populations that will have a slight increase in female to male ratios) in the North and "younger men"(refering to a higher male to female ratio in younger populations-as well as selective gender bias) in the South, or underdeveloped world. Maybe the influence an older, somewhat more femine population in the West might be a moderating influence governing our policies with regard to the rest of the world? Just a thought. But-waite a minute! Life extension will be available to the men as well as the women, unless we find more men just wanting to "roll over and die". Mr Fukuyama seems to be saying that changing anything that "makes us human" is wrong. I have a question to pose to him and any of you out there. What is so good about being "human"? Lets see, we are a vehicle for the "The Selfish Gene" which only cares about its transmission from one temporary entity to the next-and after the age of reproduction-who cares? Right? So we are disposable!Birth-Shcool-Work-Reproduction-Death. Right about when we start to begin to live, the genetic time bomb begins to visabley manifest itself. Like Francis, I was born in the middle of the "Baby Boom" generation. I am looking forward to human intellegence being able to preserve precious consciousness indefinitley. I have always known it would happen and I have a better than 50% chance at seeing this. This was considered impossible 30 years ago and I (and others like me) would state this and be shrugged off. What is really of concern to me is that now, we know it is possible but that some believe we should just "roll over and die"! Rediculous! We should persue radical life extension and also encourage near zero total birth rates so we can escape the Birth-School-Work-Reproduction-Death senerio!
• Review:: 'A frightening glance at a future already being born out... What is human? What is morality? What is that essential core that makes us more than animals but constrains us from becoming amoral "posthuman" entities? These are vital questions that have plagued humanity for eons and, while Mr. Fukuyama does not pretend to have the answers to thousands of years of philosophical angst, he does recast the questions themselves in forms more applicable to 21st Century technological concerns. More than in any time in our past, the march of time and the advance of technology are putting the meaning of what is human into question and the concerns raised here are being born out in our news reports on a nightly basis. Is psychopharmacology changing the very definition of a "normal" state of mind? When one in ten Americans is on Prozac and a huge, and increasing, number of our children are subjected to pharmacological "cures" for manufactured conditions (Hello ADHD), self-reflection is vital. When advances in biotech are allowing us to engage in large scale eugenics, and this IS what it is, by aborting female fetuses, as in China and South Asia, by aborting genetic abnormalities, see the plummeting number of births with cleft palates and Downs Syndrome, and human cloning is the cusp of reality in S.Korea and elsewhere, we MUST reflect on where we are heading as a civilization. Some people think Mr. Fukuyama is scaremongering here, but it is not scaremongering to raise valid, if unpleasant, questions. It is essential to question that if by changing the chemical balance of the human mind or engineering specific "advances" into our genes we are undermining that part of us that contains our morality and constrains us from our baser instincts. It is not only valid but imperative that we not accept any sort of new reality, any new normal, blindly and without question but subject it to what we as humans are best at; doubt, cynicism, and uncomfortable probing questions. The end of the book bogs down a bit as Mr. Fukuyama attempts to offer potential solutions to these problems but that does not in any way impugn the value of his arguments here. In my humble opinion, in this era, the very definition of what is "human" is being put to the question and introspection and doubt are crucial to humanity as a whole. That is why this tome is invaluable and should be required reading.

• Similar books:
• Redesigning Humans- Our Inevitable Genetic Future
• Life, Liberty and the Defense of Dignity- The Challenge for Bioethics
• More Than Human- Embracing the Promise of Biological Enhancement
• Radical Evolution- The Promise and Peril of Enhancing Our Minds, Our Bodies -- and What It Means to Be Human
• Trust- The Social Virtues and The Creation of Prosperity